This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Memorandum Of Agreement: Training State Regulators To Advance The Quality Of Orthopaedic Care For China

China is among the fast-growing emerging markets for medical devices, with high unmet needs in the treatment of musculoskeletal diseases, including arthritis.  Primarily associated with the elderly, arthritis is on the rise as China's population ages.  According to recently released statistics by the China National Committee on Aging, the number of Chinese senior citizens is expected to increase from the current 185 million to 487 million, or 35 percent of the population, by 2053.

This joint effort by Zimmer and the BJDA to hold training sessions lays the groundwork for additional opportunities to share knowledge in the near future.   This collaboration will further enhance the safety and effectiveness of medical devices, provide musculoskeletal health solutions and improve the quality of life for patients in China.

About the CompanyFounded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2011 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 9,000 employees worldwide.

For more information, please visit our website at  www.zimmer.com.

SOURCE Zimmer Holdings, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,956.55 -81.42 -0.45%
S&P 500 2,099.17 -9.75 -0.46%
NASDAQ 5,017.0140 -43.2320 -0.85%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs